Table 2.
Categorical glucose parameters and functional outcomes.
| Independent outcome (mRS 0–2) | Dependent outcome (mRS 3–6) | P-value | |
|---|---|---|---|
| N | 200 | 292 | |
| Initial blood glucose, n (%) | 0.50 | ||
| 1Q (≤104 mg/dl) | 58 (29.0) | 67 (22.9) | |
| 2Q (105–125 mg/dl) | 48 (24.0) | 77 (26.4) | |
| 3Q (126–152 mg/dl) | 49 (24.5) | 74 (25.3) | |
| 4Q (≥153 mg/dl) | 45 (22.5) | 74 (25.3) | |
| Mean blood glucose, n (%) | 0.005 | ||
| 1Q (≤110 mg/dl) | 64 (32.0) | 61 (20.9) | |
| 2Q (111–124 mg/dl) | 54 (27.0) | 68 (23.3) | |
| 3Q (125–143 mg/dl) | 45 (22.5) | 78 (26.7) | |
| 4Q (≥144 mg/dl) | 37 (18.5) | 85 (29.1) | |
| Maximum blood glucose, n (%) | 0.12 | ||
| 1Q (≤131 mg/dl) | 54 (27.0) | 69 (23.6) | |
| 2Q (132–154 mg/dl) | 55 (27.5) | 68 (23.3) | |
| 3Q (155–182 mg/dl) | 39 (19.5) | 85 (29.1) | |
| 4Q (≥183 mg/dl) | 52 (26.0) | 70 (24.0) | |
| Standard deviation, n (%) | 0.28 | ||
| 1Q (<12.5) | 48 (24.0) | 76 (26.0) | |
| 2Q (12.5–18.9) | 46 (23.0) | 77 (26.4) | |
| 3Q (18.9–28.3) | 46 (23.0) | 74 (25.3) | |
| 4Q (≥28.4) | 60 (30.0) | 65 (22.3) | |
| Coefficient of variance, n (%) | 0.005 | ||
| 1Q (≤0.1) | 48 (24.0) | 80 (27.4) | |
| 2Q (0.1–0.15) | 39 (19.5) | 86 (29.5) | |
| 3Q (0.15–0.21) | 54 (27.0) | 75 (25.7) | |
| 4Q (>0.21) | 59 (29.5) | 51 (17.5) | |
| J index, n (%) | 0.42 | ||
| 1Q (≤15.8) | 57 (28.5) | 66 (22.6) | |
| 2Q (15.8–21.0) | 51 (25.5) | 72 (24.7) | |
| 3Q (21.0–28.4) | 45 (22.5) | 78 (26.7) | |
| 4Q (>28.4) | 47 (23.5) | 76 (26.0) |
The quartiles of each parameter contained a quarter of the cohort population.